Saturday 17 October 2026
Export INDP’s income statement to Excel — free account
Indaptus Therapeutics, Inc.
INDP Healthcare Biotechnology
In the quarter to June 2026, EPS grew 99.8% and free cash flow grew 52.0%, each against the same quarter a year earlier.
2.63
0.22
−7.72%
Follow INDP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (318.04%) | (931.79%) | (588.41%) | (317.98%) |
+8 more TTM periods Free account |
|
| (163.84%) | (496.74%) | (250.45%) | (223.71%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(135.62%) | (1,511.15%) | (661.53%) | (401.16%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.13) | (1.53) | (15.34) | (15.07) | |
Free Cash Flow |
(14.70) | (16.79) | (14.82) | (15.03) | |
| Other line items | |||||
Cash ROIC |
(64.10%) | (611.41%) | (127.14%) | (144.07%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.95 | 0.89 | 0.71 | 0.89 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (1.53) | (15.34) | (15.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates